Cognitive Behavioral Therapy for Insomnia (CBT-I)
Cognitive Behavioral Therapy for Insomnia (CBT-I) is a cognitive-behavioral protocol built on Richard Bootzin's stimulus control (1972) and Arthur Spielman's 1987 model of insomnia and sleep restriction, and manualized by Charles Morin in 1993 and by Michael Perlis and colleagues in 2005. Its core mechanism: sleep restriction and stimulus control consolidate sleep drive and decondition wakefulness; cognitive restructuring reduces hyperarousal and catastrophic thinking about sleep. This catalogue links it to depression, anxiety and PTSD, typically in individual or group format, short-term (4–8 sessions).
Related condition topics
These links support exploration. They do not establish that CBT-I is effective or recommended for each condition.
How Cognitive Behavioral Therapy for Insomnia works
Sleep restriction and stimulus control consolidate sleep drive and decondition wakefulness; cognitive restructuring reduces hyperarousal and catastrophic thinking about sleep
Ontology
Chronic insomnia as a learned disorder of hyperarousal and conditioned sleeplessness maintained by maladaptive behaviors and beliefs, not a primary neurological deficit
Therapeutic Voice
"We're going to compress the time you spend in bed to build up your sleep drive. It will feel harder before it feels easier."
View of the Person
A person whose natural sleep capacity is intact but has been disrupted by learned behaviors and beliefs that perpetuate insomnia
Epistemology
Evidence
1 condition assessment available
An overall effectiveness assessment has not been completed. Completed assessments for specific populations appear below.
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Insomnia & Sleep Disorders
Population and scope: Adults with chronic insomnia disorder receiving multicomponent CBT-I. This assessment concerns insomnia, including when it co-occurs with another condition; it does not grade treatment of obstructive sleep apnea, circadian disorders or the co-occurring diagnosis itself.
Guideline recommendation
AASM’s 2021 recommendation 1 and VA/DoD’s 2025 recommendation 5 strongly recommend multicomponent CBT-I for adult chronic insomnia. VA/DoD recommendation 8 only weakly favors CBT-I over medication as initial treatment. AASM’s 2026 combination guideline conditionally favors CBT-I alone over starting CBT-I and medication together, with low-certainty evidence and preference-based exceptions. The guideline label therefore applies to the defined insomnia treatment, not sleep hygiene alone, every digital program, every sleep disorder or universal superiority to medication.
Source assessment dated
- American Academy of Sleep Medicine (2021-02-01; JCSM 17(2):255–262; DOI 10.5664/jcsm.8986): Behavioral and psychological treatments for chronic insomnia disorder in adults — Methods and Table 1, printed p. 256 / physical PDF p. 2; Recommendation 1 and Remarks, printed p. 257 / physical PDF p. 3
- US Department of Veterans Affairs / Department of Defense (Version 3.0; January 2025; evidence through 2024-03-31; current PDF filename dated 2025-09-15): Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea — Table 4, recommendations 5 and 8, printed/PDF p. 34
- American Academy of Sleep Medicine (2026-04-13; JCSM 22:56; evidence through June 2025): Combination treatment for chronic insomnia disorder in adults — Recommendations 1 and 2 and remark to Recommendation 2, physical PDF p. 1; Methods/Introduction, physical PDF pp. 1–2; current AASM Practice Guidelines directory
Guidelines and official sources (5)
5 clinical guideline checks
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Behavioral and psychological treatments for chronic insomnia disorder in adults
Recommendation for the stated population
AASM strongly recommends multicomponent CBT-I. Its 2021 review did not directly compare psychotherapy with medication.
Scope: Adults with chronic insomnia disorder, with or without comorbidities
- Combination treatment for chronic insomnia disorder in adults
Recommendation for the stated population
AASM conditionally favors CBT-I plus medication over medication alone, and CBT-I alone over the combination; both use low-certainty evidence and allow preference-based exceptions.
Scope: Adults with chronic insomnia; concurrent initiation of medication and CBT-I
- Management of chronic insomnia disorder in adults
Recommendation for the stated population
ACP recommends CBT-I initially; after an unsuccessful course, it suggests shared decisions about adding short-term medication.
Scope: Adults with chronic insomnia disorder
- Daridorexant for treating long-term insomnia (TA922)
Discussed in the source
NICE describes CBT-I as the standard first treatment; daridorexant eligibility requires CBT-I to have failed, be unavailable or be unsuitable. This is a drug technology appraisal, so identify that context.
Scope: Adults with long-term insomnia being considered for daridorexant
- Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea
Recommendation for the stated population
VA/DoD strongly recommends CBT-I and weakly favors CBT-I over medication initially. These recommendations address insomnia, not treatment of its comorbid diagnoses.
Scope: Adults with chronic insomnia disorder; initial treatment selection.
Recorded material under review
The existing notes below are retained separately from assessment records. These recorded claims await source checking, including study design, recommendations and numerical estimates.
AASM's 2021 guideline identified 66 randomized CBT-I trials in adults with chronic insomnia, compared with waiting-list, minimal-intervention or placebo controls; 49 supplied data for at least one critical outcome. This is the guideline's review set, not a current total.
Sources for the corrected statements:
AASM's 2021 guideline strongly recommends multicomponent CBT-I for adults with chronic insomnia, including people with comorbid conditions. VA/DoD's 2025 guideline suggests CBT-I before medication as initial treatment, with a weak recommendation (recommendation 8). These statements concern insomnia treatment; they do not establish treatment effects on the underlying comorbid diagnosis or validate every digital programme.
Sources for the corrected statements:
Training and certification
Graduate training in CBT; additional specialized training in CBT-I protocols recommended for clinical use
CBSM and CBT-I specific training through AASM, UPenn, and other programs
Variable; workshop training common (8–16 hrs) plus supervised practice
$500–2K for specialized training
Equity & Cultural Adaptations
Clinical cautions and blind spots
Assessment and precautions
Assess co-occurring sleep apnea and other sleep disorders and coordinate their treatment; diagnosed apnea awaiting treatment does not automatically exclude all CBT-I in appropriately screened patients. The sleep-restriction component may be unsuitable or require modification when there is severe daytime sleepiness, safety-critical work, vulnerability to mania or hypomania, or poorly controlled seizures. Substance use, intoxication or withdrawal, and other unstable conditions require separate assessment and coordinated care.
Sources for the corrected statements:
Blind spots
Sleep restriction can be challenging for people with bipolar disorder (may trigger mania); requires motivation and tolerance of short-term worsening; group or digital formats may not address comorbidities
Philosophical roots
Behavioral learning theory (Pavlov, Skinner); cognitive appraisal theory; Spielman's 3P model (predisposing, precipitating, perpetuating factors)
Compared with other approaches
Test Yourself
Why does sleep restriction, giving less time in bed, improve insomnia?
Show answer
Sleep restriction is intended to consolidate sleep drive by matching time in bed more closely to time asleep. It is one component of CBT-I. AASM's 2021 recommendation for sleep restriction used alone is conditional, whereas its recommendation for multicomponent CBT-I is strong.
Sources for the corrected statements: